Precision Medicine in Oncology^®

Perseverance Is the Name of the Game With HER3 Research in Solid Tumors

Despite a reasonable expectation that expression of HER3 and its ligand heregulin would be predictive biomarkers for HER3-targeted therapy, their usefulness in clinical trials has been hit-and-miss. Nevertheless, investigators have persevered, and new...
Read More >>

Potential Immunotherapy Response Markers Emerge in Metastatic Breast Cancer

Expert Outlines Next Steps for Liquid Biopsies in Oncology

PD-L1: A Biomarker With Baggage

CMS Expands Coverage of NGS Diagnostic Tests for Germline Ovarian, Breast Cancers

Gene Signatures Predict for Radiation Response in Breast Cancer

View More Stories >>

View Conference Coverage

2020 Transplantation & Cellular Therapy Meetings

2020 Winter Lung Cancer Conference

2020 Genitourinary Cancers Symposium

2020 SGO Winter Meeting

2020 Gastrointestinal Cancers Symposium

Dr. Eward on the Unmet Need for Novel Agents for TGCT and Sarcoma

Dr. Bardia on the Clinical Utility of Liquid Biopsies in Breast Cancer

Dr. Levy on Ongoing Research Evaluating the Use of Liquid Biopsies in Lung Cancer

Dr. Putcha on Blood-Based Detection of Early-Stage CRC

Dr. Gadgeel on the Utility of Liquid Biopsies in Lung Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Hepatocellular Carcinoma: Antiangiogenic Therapy Options

Targeted Therapy for KRAS-Mutant NSCLC

Treatment of NSCLC With RET Fusions

Treatment of Germline BRCA with PARP and Checkpoint

OncLive houses thousands of videos that provide updates and information.
See more Videos

Emerging Agents for HER2+ mBC: Targeted Therapeutics

Evolving Landscape of HER2-Targeted Therapy in Breast Cancer

TRK Inhibition: Future Challenges and Evolutions

Use of TRK Inhibition in Specific Tumor Types

The Importance and Evolution of NGS Testing

Envisioning Use of TRK Inhibitors in Clinical Practice

TRK Inhibition in CNS Tumors or Metastases

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Program

Treatment of Advanced Head & Neck Squamous Cell Carcinoma

Ezra Cohen, MD; Robert Ferris, MD, PhD, FACS; and Jared Weiss, MD, provide a comprehensive overview of diagnosis and treatment of advanced head and neck squamous cell carcinoma (HNSCC), including multidisciplinary care and emerging evidence surrounding novel therapies. Treatment approaches to HPV-positive and HPV-negative tumors are explored.